Barclays »

Neurogene shares owned by Barclays

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by Barclays

Quarter filed Position value Share count Share price at filing
2024-12-31 $401k 18k 22.87
2024-09-30 $623k 15k 41.93
2024-06-30 $129k 3.5k 36.41
2024-03-31 $611k 12k 50.92